These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 11375957)

  • 1. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis.
    Laurent-Puig P; Legoix P; Bluteau O; Belghiti J; Franco D; Binot F; Monges G; Thomas G; Bioulac-Sage P; Zucman-Rossi J
    Gastroenterology; 2001 Jun; 120(7):1763-73. PubMed ID: 11375957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors.
    Okabe H; Ikai I; Matsuo K; Satoh S; Momoi H; Kamikawa T; Katsura N; Nishitai R; Takeyama O; Fukumoto M; Yamaoka Y
    Hepatology; 2000 May; 31(5):1073-9. PubMed ID: 10796882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular mechanism of hepatocarcinogenesis].
    Imazeki F; Saisho H
    Gan To Kagaku Ryoho; 1999 Dec; 26(14):2154-61. PubMed ID: 10635298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity.
    Legoix P; Bluteau O; Bayer J; Perret C; Balabaud C; Belghiti J; Franco D; Thomas G; Laurent-Puig P; Zucman-Rossi J
    Oncogene; 1999 Jul; 18(27):4044-6. PubMed ID: 10435629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic changes and histopathological grades in human hepatocellular carcinomas.
    Konishi M; Kikuchi-Yanoshita R; Tanaka K; Sato C; Tsuruta K; Maeda Y; Koike M; Tanaka S; Nakamura Y; Hattori N
    Jpn J Cancer Res; 1993 Aug; 84(8):893-9. PubMed ID: 8407553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenetic tree modeling of human hepatocarcinogenesis.
    Longerich T; Mueller MM; Breuhahn K; Schirmacher P; Benner A; Heiss C
    Int J Cancer; 2012 Feb; 130(3):575-83. PubMed ID: 21400513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic alterations in hepatocellular carcinomas: associations with clinical parameters].
    Bluteau O; Laurent-Puig P; Zucman-Rossi J
    Gastroenterol Clin Biol; 2001 Dec; 25(12):1067-77. PubMed ID: 11910987
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
    Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W
    Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype.
    Boige V; Laurent-Puig P; Fouchet P; Fléjou JF; Monges G; Bedossa P; Bioulac-Sage P; Capron F; Schmitz A; Olschwang S; Thomas G
    Cancer Res; 1997 May; 57(10):1986-90. PubMed ID: 9157995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of cumulative allelic losses with tumor aggressiveness in hepatocellular carcinoma.
    Tamura S; Nakamori S; Kuroki T; Sasaki Y; Furukawa H; Ishikawa O; Imaoka S; Nakamura Y
    J Hepatol; 1997 Oct; 27(4):669-76. PubMed ID: 9365043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.
    Rashid A; Wang JS; Qian GS; Lu BX; Hamilton SR; Groopman JD
    Br J Cancer; 1999 Apr; 80(1-2):59-66. PubMed ID: 10389978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic stability prevails in North-African hepatocellular carcinomas.
    Pineau P; Ezzikouri S; Marchio A; Benazzouz M; Cordina E; Afifi R; Elkihal L; Khalfallah MT; Mestiri H; Tebbal S; Berkane S; Debzi N; Triki H; Dejean A; Iguer F; Bahri O; Essaid El Feydi AE; Benjelloun S
    Dig Liver Dis; 2007 Jul; 39(7):671-7. PubMed ID: 17531558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway.
    Abraham SC; Wu TT; Hruban RH; Lee JH; Yeo CJ; Conlon K; Brennan M; Cameron JL; Klimstra DS
    Am J Pathol; 2002 Mar; 160(3):953-62. PubMed ID: 11891193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal instability and human hepatocarcinogenesis.
    Nishida N; Nishimura T; Ito T; Komeda T; Fukuda Y; Nakao K
    Histol Histopathol; 2003 Jul; 18(3):897-909. PubMed ID: 12792902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple chromosomal abnormalities in human liver (pre)neoplasia.
    Raidl M; Pirker C; Schulte-Hermann R; Aubele M; Kandioler-Eckersberger D; Wrba F; Micksche M; Berger W; Grasl-Kraupp B
    J Hepatol; 2004 Apr; 40(4):660-8. PubMed ID: 15030983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
    Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
    Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
    Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
    J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance.
    Wong CM; Fan ST; Ng IO
    Cancer; 2001 Jul; 92(1):136-45. PubMed ID: 11443619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects.
    Buendia MA
    Med Pediatr Oncol; 2002 Nov; 39(5):530-5. PubMed ID: 12228912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.